MRU Stock Analysis: Metro | TO
Grocery Stores | TO, Canada | Market Cap: 20.623m CAD | 12M Return: 3.4% | CA59162N1096 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 55.0M
EPS Trend: 84.5%
Qual. Beats: 0
Rev. Trend: 98.6%
Qual. Beats: 2
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.8 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Metro Inc. is a Canadian food and pharmacy retailer, franchisor, distributor, and manufacturer headquartered in Montreal. Its stores operate under banners including Metro, Food Basics, Super C, and Jean Coutu, and it also offers online grocery shopping.
The company sells groceries, prepared foods, and pharmacy products, including private-label lines such as Selection and Personnelle. Food retail focuses on everyday essentials, while Metro’s franchising and distribution activities complement its store network.
- Food inflation and wage costs pressure grocery margins
- Super C and Food Basics growth intensifies price competition
- Pharmacy sales and private-label products support earnings growth
| Net Income: 899.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -0.41 > 1.0 |
| NWC/Revenue: 3.66% < 20% (prev 3.28%; Δ 0.38% < -1%) |
| CFO/TA 0.11 > 3% & CFO 1.55b > Net Income 899.1m |
| Net Debt (6.66b) to EBITDA (2.03b): 3.27 < 3 |
| Current Ratio: 1.43 > 1.5 & < 3 |
| Outstanding Shares: last quarter (211.9m) vs 12m ago -3.46% < -2% |
| Gross Margin: 19.57% > 18% (prev 19.80%; Δ -0.23% > 0.5%) |
| Asset Turnover: 155.0% > 50% (prev 152.8%; Δ 2.24% > 0%) |
| Interest Coverage Ratio: 8.86 > 6 (EBIT TTM 1.41b / Interest Expense TTM 159.5m) |
| A: 0.06 (Total Current Assets 2.76b - Total Current Liabilities 1.93b) / Total Assets 14.7b |
| B: 0.37 (Retained Earnings 5.45b / Total Assets 14.7b) |
| C: 0.10 (EBIT TTM 1.41b / Avg Total Assets 14.5b) |
| D: 0.90 (Book Value of Equity 6.96b / Total Liabilities 7.73b) |
| Altman-Z'' = 3.18 = A |
| DSRI: 1.08 (Receivables 999.8m/903.0m, Revenue 22.5b/21.8b) |
| GMI: 1.01 (GM 19.80% / 19.57%) |
| AQI: 0.98 (AQ_t 0.46 / AQ_t-1 0.47) |
| SGI: 1.03 (Revenue 22.5b / 21.8b) |
| TATA: -0.04 (NI 899.1m - CFO 1.55b) / TA 14.7b) |
| Beneish M = -2.95 (Cap -4..+1) = A |
As of November 13, 2026, the stock is trading at CAD 98.59 with a total of 420,470 shares traded. Over the past week, the price has changed by -0.88%, over one month by +8.48%, over three months by +10.54% and over the past year by +3.41%.
Current recommended Stop Loss: 94.60 (which is 4% or 2.3 ATR below the current price).
Metro has no consensus analysts rating.
P/E Trailing = 23.4086
P/E Forward = 19.1205
P/S = 0.9248
P/B = 2.9525
P/EG = 2.2744
Revenue TTM = 22.5b CAD
EBIT TTM = 1.41b CAD
EBITDA TTM = 2.03b CAD
Long Term Debt = 3.17b CAD (from longTermDebt, last quarter)
Short Term Debt = 307.2m CAD (from shortTermDebt, last quarter)
Debt = 6.71b CAD (from shortLongTermDebtTotal, last quarter) + Leases 1.76b
Net Debt = 6.66b CAD (calculated: Debt 6.71b - CCE 49.9m)
Enterprise Value = 27.3b CAD (20.6b + Debt 6.71b - CCE 49.9m)
Interest Coverage Ratio = 8.86 (Ebit TTM 1.41b / Interest Expense TTM 159.5m)
EV/FCF = 24.57x (Enterprise Value 27.3b / FCF TTM 1.11b)
FCF Yield = 4.07% (FCF TTM 1.11b / Enterprise Value 27.3b)
FCF Margin = 4.94% (FCF TTM 1.11b / Revenue TTM 22.5b)
Net Margin = 4.00% (Net Income TTM 899.1m / Revenue TTM 22.5b)
Gross Margin = 19.57% ((Revenue TTM 22.5b - Cost of Revenue TTM 18.1b) / Revenue TTM)
Gross Margin QoQ = 18.77% (prev 20.09%)
Tobins Q-Ratio = 1.86 (Enterprise Value 27.3b / Total Assets 14.7b)
Interest Expense / Debt = 2.38% (Interest Expense 159.5m / Debt 6.71b)
Taxrate = 24.54% (293.0m / 1.19b)
NOPAT = 1.07b (EBIT 1.41b * (1 - 24.54%))
Current Ratio = 1.43 (Total Current Assets 2.76b / Total Current Liabilities 1.93b)
Debt / Equity = 0.96 (Debt 6.71b / totalStockholderEquity, last quarter 6.96b)
Debt / EBITDA = 3.27 (Net Debt 6.66b / EBITDA 2.03b)
Debt / FCF = 6.00 (Net Debt 6.66b / FCF TTM 1.11b)
Total Stockholder Equity = 6.99b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.20% (Net Income 899.1m / Total Assets 14.7b)
RoE = 12.87% (Net Income TTM 899.1m / Total Stockholder Equity 6.99b)
RoCE = 13.91% (EBIT 1.41b / Capital Employed (Equity 6.99b + L.T.Debt 3.17b))
RoIC = 8.19% (NOPAT 1.07b / Invested Capital 13.0b)
WACC = 3.41% (E(20.6b)/V(27.3b) * Re(3.94%) + D(6.71b)/V(27.3b) * Rd(2.38%) * (1-Tc(0.25)))
Discount Rate = 3.94% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -99.21 | Cagr: -3.03%
[DCF] Terminal Value 75.12% ; FCFF base≈1.12b ; Y1≈1.10b ; Y5≈1.12b
[DCF] Fair Price = 52.03 (EV 17.5b - Net Debt 6.66b = Equity 10.9b / Shares 209.3m; r=8.35% [WACC [floored]]; 5y FCF grow -2.37% → 2.50% )
EPS Correlation: 84.51 | EPS CAGR: 4.00% | SUE: 0.0 | # QB: 0
Revenue Correlation: 98.60 | Revenue CAGR: 2.89% | SUE: 1.87 | # QB: 2
EPS current Quarter (2026-12-31): EPS=1.22 | Chg30d=-1.26% | Revisions=+0% | Analysts=6
EPS current Year (2026-09-30): EPS=4.52 | Chg30d=-0.14% | Revisions=+0% | GrowthEPS=-5.3% | GrowthRev=+2.4%
EPS next Year (2027-09-30): EPS=5.43 | Chg30d=-0.74% | Revisions=+0% | GrowthEPS=+20.3% | GrowthRev=+3.8%
[Analyst] Revisions Ratio: +0% (up=0, down=0)